ABSTRACT: Joint mobility decreases in the elderly and in diabetics, this process is thought to be caused by accumulation of advanced-glycation end products (AGEs). Here, we aimed to elucidate the role of AGEs in joint contracture formation in rat knees. Rats were injected with ribose or saline into the knees twice weekly for 8 weeks. Pentosidine (AGE) levels were measured in the knee-joint tissues. After serial injections, rats were subjected to unilateral knee-joint immobilization in a flexion position for various periods. At day 21, the passive knee ranges of motions (ROMs) were measured. Knee joint histopathology were assessed, and the expression of fibrotic genes in the posterior joint capsules was examined using real-time PCR. Ribose injection induced a 7.0-fold increase in pentosidine levels relative to saline injection. Joint immobilization resulted in equal myogenic ROM restriction in both groups. Arthrogenic ROM restriction was greater with ribose injection in the immobilized joints (p < 0.05), but was not affected in nonimmobilized joints. Type-I (COL1A1) and type-III (COL3A1) collagen gene expression increased significantly in immobilized joints relative to nonimmobilized joints in the ribose group, but was not affected in the saline group. Ribose injection increased COL1A1 expression slightly and COL3A1 expression significantly in immobilized joints. Histologically, inflammatory changes appeared at day 3 of immobilization and peaked at day 7. These responses trended to be more severe and prolonged in the ribose group than in the saline group. Our data provide evidence for a causal relationship between AGEs and joint contracture formation following immobilization. ß
Joint contracture, defined as a limitation in active and passive range of motion (ROM) on the affected joints, is a common complication of various nonphysiological conditions in joints of orthopedic patients, including neurological disorders, 1,2 prolonged immobilization, [3] [4] [5] and inflammation. [6] [7] [8] Restriction of ROM limits the performance of stable and functional movements and restricts activities of daily living in affected patients. The major contributors to joint contracture are divided into articular and muscular components. 3, 9 Muscular limitation following knee-joint immobilization is dominant in the early phase ( 2 weeks of immobilization) but articular limitation becomes dominant over time (!4 weeks of immobilization) in a rat model. 3 Importantly, arthrogenic contracture due to long-term immobilization is irreversible, and is not expected to recover spontaneously. In clinical practice, passive joint movements such as stretching are widely used to improve and prevent contracture; however, meta-analyses show that the effects are either not clinically important 10 or not clear. 11 Therefore, development of new therapeutic strategies is necessary for preventing and treating joint contracture.
Joint contracture is accompanied by changes in the periarticular components. In the joint capsule, it is reported to be associated with a decrease in water content, 12 adhesion, 13 and shortening 9 of the synovial membrane, as well as increased elasticity. 14 In addition, many investigators have focused on joint capsule fibrosis, represented by collagen deposition, as a key factor in joint capsule stiffness. In posttraumatic contracture, there is a consensus that collagen proteins and fibrosis-related genes are increased in the joint capsule in rats 15 and rabbits. 16, 17 In immobilization-induced contracture, however, collagen expression patterns in joint capsules are inconsistent among studies. [18] [19] [20] [21] These findings suggest that arthrogenic joint contracture is a result of multifactorial etiopathogenesis.
It is known that the stiffness of connective tissues is altered by nonenzymatic collagen cross-linking by advanced-glycation end products (AGEs). AGEs increase in the elderly 22 and in diabetes patients 23 in low-turnover tissues, such as joint cartilage, tendon, and skin. Accumulation of AGEs induced by incubation with threose 24 resulted in increased stiffness of the collagen network in human articular cartilage. Therefore, it is possible that accumulation of AGEs in joint capsules also increases stiffness and restricts ROM as a result of arthrogenic contracture. Indeed, ROM in multiple joints reduced in elderly and diabetes patients, and this is thought to be the result of increasing AGEs. 25 In addition, AGEs bind to their receptors (RAGEs) and stimulate a RAGE-mediated NF-kB signaling cascade, leading to proinflammatory changes in fibroblast-like synovial cells. 26 Importantly, inflammation is known to be involved in the development of arthrofibrosis and subsequent joint contracture. 7, 8, 27 Epidemiologic studies have shown that several rheumatic manifestations, including contracture, increase in diabetes patients with suspected AGE accumulation. 25 Combined, the above evidence suggests that AGE accumulation plays a key role in the development and progression of joint contracture. There are however few reports investigating this relationship. Wood et al. 28 demonstrated that aging increases passive muscle stiffness, with a concomitant increase in hydroxyproline (the main amino acid in the collagen protein) and AGEs in mouse tibialis anterior muscle, but AGEs were not analyzed in the joint capsule. Lee et al. 29 investigated the expression of the AGE marker pentosidine in the posterior joint capsule in immobilized rat knees. They used immunohistochemistry and observed pentosidine accumulation in the joint capsule following 8 weeks of immobilization. However, the accumulation was apparently delayed when ROM became restricted, which occurred after 2 weeks of immobilization. Thus, a substantial part of the role of AGEs in the formation of joint contracture is still unknown.
In this study, we investigated whether joint contracture is generated by AGE accumulation in the joint capsule, which was induced by intra-articular injection of ribose in a rat model. In addition, we investigated the effect of AGEs on the progression of joint contracture following immobilization. We hypothesize that AGE accumulation in the joint capsule results in arthrogenic joint contracture, and that the progression of ROM restriction following joint immobilization is more severe in joints in which AGEs have accumulated.
MATERIALS AND METHODS

Experimental Animals
Experimental procedures were approved by the Committee of Research Facilities for Laboratory Animal Sciences at Hiroshima International University. Eight-week-old male Wistar rats weighing 195 AE 8 g (mean AE standard deviation) were used in this study. The animals were housed in standard cages, given access to food and water ad libitum, and maintained in a thermoneutral environment (22-25˚C) with a 12-h light-dark cycle.
Induction of AGE Accumulation
Under anesthesia with intra-peritoneal injection of sodium pentobarbital (50 mg/kg), both sides of the knee joints were injected with 100 ml of 2.0 M D-(À)-ribose (Sigma, St. Louis, MO) twice weekly for 8 weeks (16 injections altogether) in the ribose group (n ¼ 8) and an equal volume of saline was injected in the saline group (n ¼ 9). Six rats were used to assess AGE accumulation in joint tissues. ROM, joint histology, histomorphometry of the synovial intima length and collagen density, and fibrosisrelated gene expression were investigated in 11 rats after immobilization for 21 days. In addition, 40 rats were used to investigate joint swelling and histology after immobilization. Ribose (n ¼ 20) or saline (n ¼ 20) was injected into the right knee of the rats in this group following the same protocol as described above. The experimental design is presented in Figure 1 .
Joint Immobilization
Joint immobilization was conducted according to the method described previously. 4 In brief, under anesthesia with an intraperitoneal injection of sodium pentobarbital (0.5 ml/kg), Kirschner wires were inserted into the femur and tibia of the rat's right knee, and the knee was fixed by wire and resin at 140˚flexion (Fig. 2) . The left knee joint was not immobilized, so as to retain the animal's mobility. At day 21 of immobilization, the knees were divided into four groups: Intact side, saline group (saline/nonIm, n ¼ 6); immobilized side, saline group (saline/Im, n ¼ 6); intact side, ribose group (ribose/nonIm, n ¼ 5); immobilized side, ribose group (ribose/Im, n ¼ 5) (Fig. 1B) .
The additional group of 40 rats was randomly divided into the two equally sized saline and ribose groups, and their knees were immobilized using the same methods as described above for 0, 3, 7, and 14 days (n ¼ 5 each; Fig. 1C ).
Pentosidine Levels in Joint Capsule and Cartilage
Four days after the last intra-articular injection, six rats were sacrificed to measure the pentosidine levels in their posterior joint capsules. After the sacrifice, posterior joint capsules were dissected from both knees of the animals in both the saline and ribose groups (three rats and six legs per (Fig. 1A) . Joint cartilage was scraped from the femoral condyles in both knees using a razor blade, and was stored at À80˚C until analysis. As a content of AGE accumulation, the pentosidine levels in the joint cartilage and capsule tissues were measured. Cartilage and capsule samples were dried and weighed before acid hydrolysis. Pentosidine levels were determined using high-performance liquid chromatography (HPLC) according to standard procedures. 30, 31 Pentosidine was quantified using a standard curve constructed from standard samples. Pentosidine content of samples was normalized to the dry weight of the tissues.
ROM Measurement
At day 21 of immobilization, passive knee-joint ROM was measured as described previously 4, 32 before and after transection of the knee flexor muscles. In brief, animals were deeply anesthetized with sodium pentobarbital (0.5 ml/kg). If necessary, supplemental diethyl ether inhalation was added to completely inhibit muscle contraction. After removing the external fixator and skin, three color markers were placed corresponding to the greater trochanter, knee lateral joint space, and lateral malleolus. The femur was fixed at 90˚hip flexion, and a 14.6-N Á mm extension moment was applied to the knee joint. Knee joint ROM was measured using the 3D motion analysis system KinemaTracer (Kissei Comtec, Nagano, Japan) and three video cameras (Tokina, Tokyo, Japan). The markers in the filmed images were traced. The KinemaTracer software used to analyze the coordinates was calibrated by recording a cube of known size. The angle between the femur (the greater trochanter to the knee lateral joint space) and the fibula (the knee lateral joint space to the lateral malleolus) was calculated as the knee extension ROM. After sacrifice via over-inhalation, the knee flexor muscles were transected to remove the myogenic effect on ROM, and the ROM measurement was repeated. All measurements were performed on both sides of each knee.
Assessment of Joint Swelling
To assess the inflammatory status of the,joint swelling, the mediolateral diameter of both knee joints was measured using manual calipers (Mitsutoyo Instruments, Tokyo, Japan) at days 0, 3, 7, and14 of immobilization in both injectate groups. All measurements were performed by one operator. Joint width ratios were calculated by dividing the mediolateral diameter of the immobilized side (right) by that of contralateral side (left).
Tissue Preparation
The knee joints were histologically analyzed to investigate the effect of the morphological alterations on joint contracture formation. After the ROM measurement, the knee joints from both sides were dissected and immersion-fixed in 0.1 M phosphate-buffered 4% paraformaldehyde (pH 7.4) for 2 days at 4˚C. During fixation, the knee joint angle was approximately 90˚flexion. Samples were decalcified and embedded in paraffin. Sagittal sections 4 mm thick were cut from the center of the medial condyle. The sections were stained with hematoxylin and eosin (HE) and aldehydefuchsin-Masson Goldner (AFMG) stain to investigate the knee-joint pathology.
Histomorphometry
The posterior region of the knee joint was photographed at 2Â magnification, and the lengths of the postero-superior and postero-inferior synovial intima in the joint capsule were measured in accordance with a previous study. 20 In brief, the postero-superior synovial length was measured between the femur-synovium junction and the meniscus, and the posteroinferior synovial length was measured between the meniscus and the tibia-synovium junction. Measurements were conducted using ImageJ software (National Institutes of Health, Bethesda, MD). Total synovial length was obtained by summing the postero-superior and postero-inferior synovial lengths.
Quantification of Collagen Density in Joint Capsule
To clarify the fibrotic changes in the posterior joint capsules, we evaluated collagen density using the method described in our previous study. 4 In AFMG-stained sections, the posterior joint capsule was photographed just behind the meniscus at 20Â magnification with a light microscope (BX-51; Olympus, Tokyo, Japan) and a digital camera (DS-Fi1, Nikon, Tokyo, Japan) and analyzed with ImageJ software. Using the Split Channels function, the green areas, which represented collagen, were isolated from the original color image. Using the Threshold function, an arbitrary threshold was set to determine the green-stained area. Collagen density was calculated as the percentage of collagen-positive area by dividing the green-stained area by the total joint capsule area.
Real-Time PCR
Paraffin sections (thickness 20 mm) were cut using a microtome, and the posterior joint capsules from both sides of the knee were carefully extracted using tweezers under a stereoscopic microscope. Total RNA was isolated using an RNeasy FFPE kit (Quiagen, Hilden, Germany) according to manufacturer's protocol. Reverse transcription was carried out using total mRNA and the SuperScript III First-Strand Synthesis System (Invitrogen, Grand Island, NY). Quantitative analysis of mRNA was performed with the ABI-7300 Fast Real-time PCR system (Applied Biosystems, Waltham, MA) using Taqman Gene Expression Assays (Applied Biosystems) for type-I collagen (COL1A1; Rn01463848_m1), type-III collagen (COL3A1; Rn01437681_m1), TGF-b1 (Rn00572010_m1), Interleukin-1b (1L-1b) (Rn00580432_m1) mRNA, and ribosomal protein S18 rRNA (Rn01428913_gH). All mRNA levels were calculated as ratios of the quantity of ribosomal protein S18 RNA in the same cDNA sample. The concentration of the total RNA extracts was not sufficient to measure OD values accurately, but amplification curves were regular and uniform for all samples. It was therefore assumed that the quality of the RNA samples was acceptable for the quantitation of gene expression levels.
Statistical Analysis
All data were expressed as mean AE standard deviation (SD). Statistical analysis was performed using Dr. SPSS II for Windows (SPSS Japan, Tokyo, Japan). Data were tested for normal distribution and equality of variance using the Kolmogorov-Smirnov and Levene's tests, respectively. Differences in the pentosidine levels in cartilage and joint capsules between the saline and ribose groups were evaluated using Mann-Whitney's U-test. Two-way analysis of variance (ANOVA) was used to detect the effects of the ribose injection, immobilization, and their interaction with ROM, synovial intima length, mRNA expression levels, and joint width ratios. For each ANOVA model indicating a significant direct or interaction effect, post hoc Bonferroni tests were performed to localize the effects. A p-value of <0.05 was considered statistically significant.
RESULTS
Pentosidine Content
Eight weeks of intra-articular injection with ribose markedly increased pentosidine levels relative to saline injection into the joint capsule (Fig. 3A, 9 .2-fold, p ¼ 0.004) and the joint cartilage (Fig. 3B, 7 .0-fold, p < 0.001).
Range of Motion
Based on the knee extension ROM prior to the myotomy (ROM þ m), joint immobilization induced a significant reduction in ROM relative to the nonimmobilized joints in both the saline (saline/nonIm vs. saline/Im: 149 AE 8˚vs. 100 AE 4˚, p < 0.001) and the ribose group (ribose/nonIm vs. ribose/Im: 153 AE 5˚vs. 96 AE 5˚, p < 0.001; Fig. 4A ). There were no significant differences between the saline and ribose groups in either the nonimmobilized or the immobilized joints, and there was no significant interaction effect between ribose injection and immobilization (p ¼ 0.157).
With respect to knee extension after the myotomy (ROM À m), joint immobilization also reduced ROM relative to the nonimmobilized joint in both the saline (saline/nonIm vs. saline/Im: 156 AE 2˚vs. 133 AE 4˚, p < 0.001) and the ribose group (ribose/nonIm vs. ribose/Im: 160 AE 4˚vs. 123 AE 6˚, p < 0.001; Fig. 4B ). ROM À m was smaller in the immobilized joints of the ribose group than those of the saline group (saline/Im vs. ribose/Im: 123 AE 6˚vs. 133 AE 4˚, p ¼ 0.001), but not in the nonimmobilized joints (saline/nonIm vs. ribose/ nonIm: 160 AE 4˚vs. 156 AE 2˚, p ¼ 0.152), and there was a significant interaction effect between ribose injection and immobilization (p ¼ 0.001).
Joint Histology and Histomorphometry
Histologically, there were no apparent inflammatory reactions in the posterior joint capsules in any of the groups (Figs 5A-D) . The AFMG-stained sections indicated that the collagen deposits tended to be more densely distributed in the immobilized posterior joint capsules of the ribose group than in the saline group. There was no difference in collagen density in the nonimmobilized joints between the saline and ribose groups (saline/nonIm vs. ribose/nonIm: 61 AE 6% vs. 59 AE 7%, p ¼ 0.925), but for the immobilized joints, collagen density was significantly higher in the ribose group (saline/nonIm vs. ribose/nonIm: 62 AE 5˚vs. 67 AE 3˚, p ¼ 0.044; Fig. 5E ). There was no significant interaction effect between ribose injection and immobilization on collagen density (p ¼ 0.141).
The postero-superior, postero-inferior, and total synovial intima lengths of the immobilized joints were reduced relative to those of the contralateral nonimmobilized joints in both the saline group (p ¼ 0.007, p ¼ 0.003, and p ¼ 0.001, respectively) and the ribose group (p ¼ 0.008, p ¼ 0.002, and p ¼ 0.001, respectively; Table 1 ). However, there was no significant difference With respect to joint capsule width, there were no differences between the two groups in either the nonimmobilized or the immobilized joints (p ¼ 0.544 and p ¼ 0.848, respectively). Joint immobilization resulted in a significantly larger joint capsule width in the saline group (p ¼ 0.014) but not in the ribose group (p ¼ 0.104). There was no significant interaction between the effect of ribose injection and immobilization on joint capsule width (p ¼ 0.572).
Fibrosis-Related Gene Expression
Gene expression of TGF-b1 was 1.0-, 0.9-, and 0.8-fold that in the saline/nonIm group in the saline/Im, ribose/nonIm, and ribose/Im groups, respectively (Fig. 6A) . TGF-b1 gene expression was thus affected by neither joint immobilization nor ribose injection.
Expression of COL1A1 relative to the saline/nonIm group was 1.2-, 1.5-, and 2.1-fold in the saline/Im, ribose/nonIm, and ribose/Im groups, respectively (Fig. 6B) . COL1A1 gene expression was thus increased in immobilized joints relative to nonimmobilized joints in the ribose group (p ¼ 0.014), but not in the saline group (p ¼ 0.182). In the immobilized joints, ribose injection resulted in a 1.5-fold increase in COL1A1 expression relative to saline injection, but this difference was not significant (p ¼ 0.066). There was no significant interaction effect between ribose injection and immobilization (p ¼ 0.296).
Expression of COL3A1 relative to the saline/nonIm group was 0.9-, 1.0-, and 2.1-fold in the saline/Im, ribose/nonIm, and ribose/Im groups, respectively (Fig. 6C ). In the immobilized joints, COL3A1 expression was significantly higher in the ribose group than in the saline group (p ¼ 0.04, 1.6-fold). Within the ribose group, COL3A1 expression was significantly higher in the immobilized joints than in the nonimmobilized joints (p ¼ 0.002, 1.7-fold). There was a significant interaction effect between ribose injection and immobilization (p ¼ 0.011).
Pathological Changes in the Joint Capsule
At day 0 of immobilization, the collagen fibers were tightly arranged in the joint capsules, and inflammatory changes in the knee joints were uncommon in the two injectate groups (Fig. 7A and E) . At day 3, inflammatory cell infiltration and edema were evident in the posterior joint capsules of rats in both groups ( Fig. 7B and F) . In the posterior joint spaces, bloodderived cells (mainly red blood cells) appeared in the posterior joint cavities. There were no apparent pathological differences between the two injectate groups at days 0 or 3.
By day 7, the inflammatory changes had progressed relative to day 3 in both groups ( Fig. 7C and G) . The extent of edema, cell infiltration into the joint capsules, and bleeding into joint spaces was slightly more severe in the ribose group than in the saline group. By day 14, the joint bleeding, edema and cell infiltration into the joint capsule had decreased relative to day 7, but these symptoms were still evident in both groups. Joint capsule inflammation was slightly more severe in the ribose group than in the saline group at days 7 and 14.
Joint Swelling
In the saline groups, knee joint width ratios were 1.02 AE 0.02, 1.04 AE 0.04, 1.06 AE 0.04, and 1.00 AE 0.03 at days 0, 3, 7, and 14 of immobilization, respectively (Fig. 7I) . This ratio was thus highest at day 7, and decreased thereafter. There was no significant 
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OZAWA ET AL. differences throughout the experimental period. In the ribose groups, joint width ratios were 1.01 AE 0.03, 1.03 AE 0.03, 1.14 AE 0.09, and 1.04 AE 0.02 at days 0, 3, 7, and 14 of immobilization, respectively. The joint width ratio at day 7 was significantly higher than on the other days (p < 0.001) and was also significantly higher than that of the saline group at day 7 (p ¼ 0.001). Finally, the interaction effect between ribose injection and immobilization was significant (p ¼ 0.021). 
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DISCUSSION
The main findings of this study are as follows: (i) AGE accumulation in joint components alone, induced by the sequential injection of ribose into the knee joint cavity, does not affect passive ROM; (ii) however, arthrogenic joint contracture following 21 days of immobilization is accelerated by a concomitant upregulation of collagen genes and protein, which results from AGE accumulation. In addition, inflammatory changes appeared in the joint capsules by day 3 of immobilization and peaked at day 7. The inflammatory reactions tended to be more severe and prolonged in the ribose group than in the saline group. This is the first study to directly elucidate the roles of AGEs in the development and progression of joint contracture.
AGE Accumulation Induced by Ribose Injection
In this study, the pentosidine level in ribose-injected joints was nine-and sevenfold that in saline-injected joints in the capsule and cartilage, respectively. DeGroot et al. 22 reported that the level of joint cartilage pentosidine in elderly humans (about 80 years) is about fivefold that in young humans (about 20 years). If joint cartilage and joint capsules follow the same pattern due to aging, the amount of AGEs in the joint capsule is probably approximately the same as that in the cartilage in the elderly. This means that our experimental conditions probably adequately mimicked an elderly human knee joint.
In our experimental setting, there was a gap of 3 weeks between the pentosidine and ROM measurements. Importantly, AGEs are only removed during tissue catabolizm, and are therefore slow to decrease in low-turnover tissues such as joint components and cartilage. It is thus unlikely that the level of AGEs would have changed substantially within 3 weeks.
Does AGE Accumulation Cause Arthrogenic ROM Restriction?
AGEs are known to affect mechanical properties by increasing the number of collagen cross-linkages in a range of tissues. For example, incubation of human joint cartilage with sugars such as ribose 33 and threose, 24 with concomitant AGE accumulation, increases stiffness. AGEs also cause an increase in the tensile stiffness of the annulus fibrosus 34 and tendon. 35 Therefore, we speculated that experimentallyinduced AGE accumulation in joint tissues would stiffen the joint components and subsequently restrict arthrogenic ROM. Contrary to our expectation, AGE accumulation did not affect joint ROM, joint capsule length or width, or the expression of collagen genes. A previous study reported that there was a significant correlation between arthrogenic joint stiffness and pentosidine-positive areas (detected via immunohistochemistry) in immobilized joint capsules. 29 However, that investigation was not conclusive as to whether AGE accumulation was a causative or correlative factor for joint ROM restriction following immobilization. Our results clearly demonstrated that AGE accumulation alone in joint tissues does not substantially affect joint ROM.
Role of the Progression of Contracture
After immobilization, arthrogenic joint ROM restriction was significantly aggravated by AGE accumulation. Many investigators have focused on the joint capsule as a key factor in arthrogenic contracture. [13] [14] [15] [16] [17] [18] [19] [20] [21] Previous studies have shown that flexion contracture Expression of the TGF-b1 gene was affected by neither joint than in nonimmobilized joints in the ribose group, but not in the saline group. In the immobilized joints, ribose injection caused COL1A1 expression to increase relative to saline injection. (C) COL3A1 expression was significantly higher in the ribose group than in the saline group, and significantly higher in the immobilized joints in the ribose group than in the nonimmobilized joints in this group.
Ã p < 0.05. Data are expressed as means AE SD.
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induced by joint immobilization is attributable to the posterior joint capsule. 20, 36, 37 Our results showed that the length of synovial intima, which is the undercoating of the joint capsule, were equally shortened by joint immobilization, regardless of injectate. Thickening of the joint capsule also occurred in the immobilized joints of both groups, but there was no difference between the two groups in this effect. Our results suggest that the arthrogenic contracture following joint immobilization was, at least in part, due to shortening of the posterior joint capsule in both injectate groups. However, the aggravation of contracture following immobilization in those joints in which AGEs had accumulated cannot be fully explained by the morphometric changes in the posterior joint capsule.
In contrast, collagen density and gene expression for type-I and type-III collagen were increased in the immobilized joints of the ribose group relative to those of the saline group. In immobilized joints, it remains controversial whether or not the expression of collagen genes and proteins increases in the joint capsule. 18, 38, 39 In traumatic joint injury, collagen deposition is apparent in the joint capsule, with concomitant ROM restriction. Increased collagen is therefore considered to be the main cause of joint contracture. 15 However, inhibition of collagen synthesis by the TGF-b1 antibody, which plays an important role in collagen expression, can suppress joint contracture induced by combined trauma and immobilization in rabbit knees. 40 We therefore suggest that aggravation of arthrogenic joint contracture in joints in which AGEs have accumulated may be caused by upregulation of the collagen genes in the posterior joint capsule.
Several studies have reported inflammatory reactions in immobilized joints. 20, 41, 42 Our results confirmed this phenomenon, by indicating several inflammatory (A-H) Postero-central knee joint capsules stained with HE from the saline (A-D) and ribose (E-H) groups at day 0 (A and E), day 3 (B and F), day 7 (C and G), and day 14 (D and H) of immobilization. At day 0, inflammatory changes were uncommon in both groups. At day 3, inflammatory cell infiltration and edema in the posterior joint capsules were equally evident in both groups. At day 7, inflammatory changes had progressed relative to day 3 in both groups, and were slightly more severe in the ribose group. At day 14, the edema and cell infiltration in the joint capsule had decreased relative to day 7, but the inflammation were still slightly more severe in the ribose group. Scale bars: 100 mm. (I) The joint swelling index and joint width ratios peaked at day 7 in both groups, but this pattern was not significant in the saline group, and the values were significantly higher in the ribose group. Ã Significant difference within the ribose groups among days (p < 0.05).
† Significant difference between the groups at the same time point (p < 0.05). Data are expressed as means AE SD.
AGEs ACCELERATES JOINT CONTRACTURE 861 responses to immobilization: Increased joint width, inflammatory cell infiltration and edema in joint capsules, and bleeding in joint cavities. Importantly, these reactions tended to be prolonged in the ribose group relative to the saline group. Joint inflammation plays a crucial role in the formation of a contracture, independently of joint immobilization 8 ; thus steroidal antiinflammatory drugs can reduce the thickening of the joint capsule and the ROM restriction following joint immobilization in rabbits. 43 Yabe et al. 42 reported that joint immobilization induced increased hypoxic markers (hypoxia-inducible factor-1 alpha, vascular endothelial growth factor, and fibroblast growth factor-2) coincident with increased inflammatory markers (interleukin-6 (IL-6), IL-1 alpha, IL-1 beta) in the joint capsule. 42 These results suggest that hypoxic conditions might be involved in the generation of arthrogenic contracture. It is thought that interaction between AGEs and their receptors (RAGEs) stimulates inflammation via the generation of reactive oxygen species induced by hypoxic conditions. 44 Stimulation of AGE-modified bovineserum albumin induces pro-inflammatory changes in osteoarthritic fibrobrast-like synovial cells in vitro. 26 Importantly, mRNA expression for type-I and type-II procollagens and collagen proteins is induced by proinflammatory cytokines stimulating fibroblast activation. 45 Combined with the above, our findings indicate that the progression of arthrogenic contracture following immobilization in joints in which AGEs have accumulated is enhanced via potentiated inflammatory reactions with concomitant fibrotic changes in the joint capsules.
Limitation
There are a limitation to the study. We measured knee joint ROMs after immobilization at only one time point (3 weeks). Joint contracture progresses depending on the immobilization period. Therefore, the differences of the ROM after myotomy between the saline and ribose group may disappear, if the immobilization is prolonged more than 3 weeks.
Perspectives
We have demonstrated that AGEs and inflammation following joint immobilization are possible targets for the treatment of joint contracture. Thus, AGE-directed therapies (e.g., dimethyl-3-phenacylthiazolium chloride, which chemically breaks AGE cross-links) and anti-inflammatory therapies (i.e., non-steroidal/steroidal anti-inflammatory drugs) may be effective in alleviating joint contracture. Alternatively, for the prevention of joint contracture, it may be necessary to avoid or minimize the immobilization period for elderly and diabetic patients in whose joints AGEs are expected to accumulate.
CONCLUSION
The present study demonstrates that AGE accumulation alone may have no effect on joint mobility.
However, arthrogenic joint contracture following immobilization may be aggravated by AGE accumulation, which is accompanied by an upregulation of collagen genes. In addition, inflammatory changes appeared in the early phases of immobilization. The extent of inflammation tended to be more severe in the presence of ribose injections than with saline injections. Our data suggest the possibility that reduction of AGEs by inhibitory drugs may be effective in retarding the progression of joint contracture.
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